Shanghai RAAS Blood Products Co., Ltd.
002252
Rank in Stocks
#3642
Shanghai RAAS Blood Products Co., Ltd. engages in the research, development,... Shanghai RAAS Blood Products Co., Ltd. engages in the research, development, production, and sale of blood products. It provides human albumin, intravenous injection of human immunoglobulin, coagulation factor products, vaccines, diagnostic reagents, and testing services. The company was founded by Kieu Hoang on October 29, 1988 and is headquartered in Shanghai, China.
Share Price
$0.70717976
Market Cap
$4.66B
Change (1 day)
-0.20%
Change (1 year)
-24.51%
Country
CN
Trade Shanghai RAAS Blood Products Co., Ltd. (002252)
Category
Healthcare
P/S ratio for Shanghai RAAS Blood Products Co., Ltd. (002252)
P/S ratio as of October 2026 TTM: 4.95
According to Shanghai RAAS Blood Products Co., Ltd. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.95. At the end of 2023 the company had a P/S ratio of 6.32.
P/S ratio history for Shanghai RAAS Blood Products Co., Ltd. from 2005 to 2026
P/S ratio at the end of each year
| Year | P/S Ratio | Change |
|---|---|---|
| 2026 (TTM) | 4.95 | -15.67% |
| 2024 | 5.87 | -7.18% |
| 2023 | 6.32 | -2.84% |
| 2022 | 6.51 | -39.30% |
| 2021 | 10.72 | -40.64% |
| 2020 | 18.06 | 24.22% |
| 2019 | 14.54 | -32.54% |
| 2018 | 21.56 | -57.21% |
| 2017 | 50.37 | 3.81% |
| 2016 | 48.52 | -10.78% |
| 2015 | 54.39 | 37.05% |
| 2014 | 39.68 | -59.96% |
| 2013 | 99.10 | 393.29% |
| 2012 | 20.09 | -11.65% |
| 2011 | 22.74 | -41.89% |
| 2010 | 39.13 | 27.96% |
| 2009 | 30.58 | 34.41% |
| 2008 | 22.75 | 41.59% |
| 2007 | 16.07 | 149.43% |
| 2006 | 6.44 | 8.58% |
| 2005 | 5.93 | 0.00% |
P/S ratio for similar companies or competitors
| Company | P/S Ratio | P/S Ratio Difference | Country |
|---|---|---|---|
| 10.02 | 102.45% |
US
|
|
| 40.55 | 719.14% |
US
|
|
| 3.96 | -19.98% |
AU
|
|
| - | - |
CH
|
|
| 10.15 | 104.96% |
NL
|
